DS Healthcare (DSKX) 10-Q 16 Nov 15 2015 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Nov. 16, 2015
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Entity Registrant Name	DS HEALTHCARE GROUP, INC.
Entity Central Index Key	1,463,959
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,015
Entity Filer Category	Smaller Reporting Company
Entity Units Outstanding		19,224,915

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current Assets
Cash	$ 1,375,290	$ 1,128,556
Accounts receivable, net of allowance for uncollectable accounts of $636,668 and $538,329 as of September 30, 2015 and December 31, 2014, respectively	3,173,576	1,809,178
Inventories, net	4,043,598	3,984,528
Prepaid expenses and other current assets	266,052	278,714
Total Current Assets	8,858,516	7,200,976
Furniture and Equipment, net	150,551	206,406
Intangible Assets, net	1,024,748	1,101,373
Other Assets	101,066	88,247
TOTAL ASSETS	10,134,881	8,597,002
Current Liabilities
Accounts payable	1,171,798	1,229,863
Accrued expenses	722,603	967,112
Note payable	437,560	350,000
Other current liabilities	863,385	886,822
Total Current Liabilities	3,195,346	3,433,797
Long Term Debt, net of current portion	15,969	24,997
TOTAL LIABILITIES	$ 3,211,315	$ 3,458,794
COMMITMENTS AND CONTINGENCIES
Shareholders' Equity
Preferred stock, $0.001 par value, 30 million shares authorized: 0 shares issued and outstanding at September 30, 2015 and December 31, 2014
Common stock, $0.001 par value, 300 million shares authorized: 19,178,985 and 16,202,268 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively	$ 19,179	$ 16,202
Additional paid-in-capital	21,063,355	14,839,695
Stock subscription	(3,947,333)	(2,500)
Accumulated deficit	(10,279,667)	(9,613,375)
Accumulated comprehensive income	106,462	(63,384)
Total Shareholders' Equity	6,961,996	5,176,638
Non-Controlling Interest	(38,430)	(38,430)
Total Shareholders' Equity	6,923,566	5,138,208
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 10,134,881	$ 8,597,002

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Condensed Consolidated Balance Sheets [Abstract]
Accounts receivable, allowance for uncollectable accounts	$ 636,668	$ 538,329
Preferred stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	30,000,000	30,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value per share	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	19,178,985	16,202,268
Common stock, shares outstanding	19,178,985	16,202,268

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Condensed Consolidated Statements of Operations and Comprehensive Loss [Abstract]
Net Revenue	$ 3,637,629	$ 3,278,117	$ 10,101,097	$ 9,707,504
Cost of Goods Sold	1,216,386	813,671	3,950,327	3,819,078
Gross Profit	2,421,243	2,464,446	6,150,770	5,888,426
Selling and marketing
Commissions and consulting	736,294	320,594	1,263,902	1,160,930
Marketing and promotion	365,924	223,910	758,446	571,668
Other selling and marketing expenses	461,402	367,841	1,208,816	1,344,007
Total selling and marketing	1,563,620	912,345	3,231,164	3,076,605
General and administrative
Salary and personnel costs	682,347	610,998	1,705,971	1,752,738
Professional fees and consulting costs	324,725	592,444	1,047,238	1,650,219
Other general and administrative expenses	388,988	465,365	868,317	938,330
Total general and administrative	1,396,060	1,668,807	3,621,526	4,341,287
Total operating costs and expenses	2,959,680	2,581,152	6,852,690	7,417,892
Operating Loss	(538,437)	(116,706)	(701,920)	(1,529,466)
Other Income (Expense)
Interest expense	(42,280)	(8,888)	(83,092)	(58,876)
Other	9,115	57,766	118,720	66,715
Total other (expense) income	(33,165)	48,878	35,628	7,839
Loss Before Income Taxes	$ (571,602)	(67,828)	$ (666,292)	(1,521,627)
Income Tax (Benefit) Expense		(13,332)		18,194
Net Loss	$ (571,602)	$ (54,496)	$ (666,292)	(1,539,821)
Net Loss Attributable to Non-Controlling Interest				(6,204)
Net Loss Attributable to Common Shareholders	$ (571,602)	$ (54,496)	$ (666,292)	$ (1,533,617)
Basic and Diluted Earnings per Share:
Weighted average shares outstanding	17,944,353	16,091,202	17,101,253	16,035,509
Loss per share	$ (0.03)	$ 0	$ (0.04)	$ (0.10)
Other Comprehensive Income:
Foreign currency translation adjustment	$ (38,398)	$ 20,567	$ 169,846	$ (35,459)
Comprehensive loss	$ (610,000)	$ (33,929)	$ (496,446)	$ (1,569,076)

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash Flows from Operating Activities:
Net Loss	$ (666,292)	$ (1,539,821)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	$ 193,681	217,426
Loss on disposal of fixed assets		7,305
Bad debts provision (recovery)	$ 120,254	(60,303)
Obsolete inventory provision (recovery)	9,970	$ (214,775)
Amortization of stock subscription related to stock issued for prepaid services	147,167
Amortization of stock-based compensation related to issued warrants	102,225
Stock issued for services	451,064	$ 117,173
Non-cash interest expense	13,609
Changes in operating assets and liabilities:
Accounts receivable	(1,484,652)	$ 366,303
Inventories	(69,040)	(687,727)
Prepaid expenses and other current assets	12,662	$ 310,264
Other assets	(12,819)
Accounts payable	(58,065)	$ (968,840)
Accrued expenses	215,290	176,452
Other current liabilities	(23,437)	460,977
Net cash used in operating activities	(1,048,383)	(1,815,566)
Cash Flows from Investing Activities:
Purchase of furniture and equipment	(2,555)	(126,506)
Net cash used in investing activities	(2,555)	$ (126,506)
Cash Flows from Financing Activities:
Proceeds from loans and notes	450,000
Repayment of loans and notes	$ (9,028)	$ (8,507)
Repayments of credit facility		(582,383)
Proceeds from sale of common stock	$ 720,000	192,000
Less issuance cost		$ (10,000)
Proceeds from exercise of warrants	$ 25,500
Net cash provided by (used in) financing activities	1,186,472	$ (408,890)
Effect of exchange rate changes on cash	111,200	(28,037)
Decrease in Cash	246,734	(2,378,999)
Cash, Beginning of Period	1,128,556	2,872,946
Cash, End of Period	1,375,290	493,947
Supplemental Information:
Cash paid for interest	$ 83,092	49,988
Supplemental Non-cash Investing and Financing Activities
Stock issued to settle debt		$ 5,000
Conversion of note and accrued interest to common stock	$ 387,100
Warrants issued in connection with notes	26,049
Sale of common stock pending proceeds, recorded as stock subscription	1,496,500
Common stock issued for prepaid services	2,595,500
Warrants issued for stock-based compensation	2,746,200
Common stock issued to settle accrued expenses	$ 422,700

ORGANIZATION AND NATURE OF BUSI

ORGANIZATION AND NATURE OF BUSINESS	9 Months Ended
	Sep. 30, 2015
ORGANIZATION AND NATURE OF BUSINESS [Abstract]
ORGANIZATION AND NATURE OF BUSINESS	NOTE 1. – ORGANIZATION AND NATURE OF BUSINESS Terms and Definitions ASC Accounting Standards Codification ASU Accounting Standards Update FASB Financial Accounting Standards Board FIFO First-in, First-out US GAAP Accounting principles generally accepted in the United States of America SEC Securities and Exchange Commission 2014-QTR Three months ended September 30, 2014 2014-YTD Nine months ended September 30, 2014 2015-QTR Three months ended September 30, 2015 2015-YTD Nine months ended September 30, 2015 VIE Variable Interest Entity Organization and Nature of Business DS Healthcare Group, Inc. (the “Company”, “DS Laboratories”, “DSKX”, “we”, “us” or “our”) was organized under the laws of the State of Florida in January 2007. The Company is engaged in the development and discovery of drug therapies for specialty pharmaceuticals and commercializes innovative personal care products for its consumer brand. The growing personal care products portfolio is distributed through a network of domestic and international retailers and distributors. The Company researches and develops its own products, which management believes keeps the Company at the forefront of innovation. Our goal is to immediately commercialize unique and disruptive technologies for personal care products that consumers use every day and to advance drug development to capitalize on both short term and long term projects.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2015
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The significant accounting policies we use for quarterly financial reporting are the same as those disclosed in Note 2 of the “Notes to Consolidated Financial Statements” included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014. Principles of Consolidation and Presentation The condensed consolidated financial statements are prepared using the accrual basis of accounting where revenues and expenses are recognized in the period in which they were incurred. The basis of accounting is US GAAP. The condensed consolidated financial statements include the accounts of the Company and its operating subsidiaries DS Laboratories, Inc., Sigma Development and Holding Co., Inc., Polaris Labs, Inc., Nutra Origin, Inc. and Divine Skin Laboratories, S.A. de CV (“DS Mexico”). Also included in the condensed consolidated financial statements are the operating activities of Velocity Storage and Packaging, LLC and Wally Group, LLC , an inactive entity, which are accounted for as VIEs. All significant intercompany balances and transactions have been eliminated in consolidation. Prior Period Reclassifications Certain prior period amounts have been reclassified for comparability with the September 3 0 , 201 5 presentation. These reclassifications had no effect on previously reported net loss. Use of Estimates The preparation of condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Although these estimates are based on management's knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results. We believe our estimates and assumptions are reasonable; however, such estimates and assumptions are subject to a number of risks and uncertainties that may cause actual results to differ materially from such estimates. Significant estimates and assumptions underlying these condensed consolidated financial statements include:  Estimates of allowances for uncollectable accounts receivable,  Estimates of inventory obsolescence and overhead and labor cost allocations,  Estimates assuming future earning capacity of our intangible assets,  Estimates of value of equity transactions for services rendered,  Estimates of returned or damaged product, and  Estimates made in our deferred income tax calculations, for which there is a full valuation allowance. Research and Development The Company currently maintains a functional laboratory employing a full time chemist and a lab technician that identify new technology, test product alternatives and improve existing formulations. In addition, our founder and President devotes a substantial portion of his time in identifying new technologies and formulations to develop new products and improve existing products with the newest technology available. Such activities are expensed in the year incurred. Such costs include laboratory suppli es, salaries, materials and consultant fees. These costs are classified as product development, salaries, selling, general and administrative expenses in the condensed consolidated statements of operations, and amounted to $ 108,731 and $ 209,445 for 2015 - YTD and 201 4 - YTD , respectively . Earnings Per Share Potentially dilutive securities are excluded from the computation of diluted net loss per share for all of the periods presented in the accompanying condensed consolidated statements of operations because the reported net loss in each of these periods results in their inclusion being anti-dilutive. Anti-dilutive securities, which consist of stock options and warrants that are not included in the diluted net loss per share calculation , consisted of an aggregate of 1,036,140 shares and 286,526 September 30 , 201 5 and 201 4, respectively . Debt Discounts The Company records, as a discount to notes, the relative fair value of warrants issued in connection with the issuances and the intrinsic value of any conversion options based on the differences between the fair value of the underlying common stock at the commitment date of the note and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized to interest expense using the interest method over the earlier of the term of the related debt or its earliest redemption date.

LIQUIDITY and GOING CONCERN

LIQUIDITY and GOING CONCERN	9 Months Ended
	Sep. 30, 2015
LIQUIDITY and GOING CONCERN [Abstract]
LIQUIDITY and GOING CONCERN	NOTE 3. – LIQUIDITY and GOING CONCERN The Company has sustained operational losses since its inception , however commencing in Q3 2014 it began to take steps to achieve profitability in the future. Such steps included increasing gross profit through price increases in Q2 2014, improved operational efficiencies and through formula changes to reduce cost without reducing efficacy. The Company also decreased overall G&A expenses by implementing cost controls over the last two quarters. At September 30 , 201 5 , the Company had an accumulated deficit of $ 10,279,667 compared to $ 9,613,375 . The Company cannot predict how long it will continue to incur further losses or whether it will ever achieve profitab ility as this is dependent upon the continued reduction of certain operating expenses, success of new and existing products and increase in overall revenue among other things . These conditions raise substantial doubt about the entity's ability to continue as a going concern. As of September 30 , 2015, the Company had $ 1,375,290 in cash. While the Company has historically financed its operations and growth primarily through the successful issuance and sale of shares of its common stock, a line of credit and the issuance of promissory notes, the Company has started several new revenue initiatives creating additional revenue streams . Some of these initiatives include: establishing an online store ( Shop.DSLaboratories.com ) which became operational in the third quarter of 2014 , generating $ 415,078 2015- YTD in net revenue . The Company also establish ed a hair treatment clinic which opened in late November 2014 which has not yet generated appreciable sales . So far in 2015 , the Company launched a range of new products. Although the Company cannot predict its success with these products or projects, all are currently under development and production and in various stages of completion. The Company has commenced implementing, and will continue to implement, various measures to address its financial condition, including but not limited to:  Continuing to seek debt and equity financing. However, there can be no assurances that the Company will be able to raise additional capital on favorable terms, or at all.  The Company completed an operational budget for 201 5-2017 that sets changes in its process es to focus on profitability . The Company is also implementing a feedback process with improved interdepartmental communication. Accordingly, the accompanying condensed consolidated financial statements have been prepared in conformity with US GAAP, which contemplates continuation of the Company as a going concern. The condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and carrying amount or classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty. The Company has commenced implementing, and will continue to implement, various measures to address our financial condition.

RECENT ACCOUNTING PRONOUNCEMENT

RECENT ACCOUNTING PRONOUNCEMENTS	9 Months Ended
	Sep. 30, 2015
RECENT ACCOUNTING PRONOUNCEMENTS [Abstract]
RECENT ACCOUNTING PRONOUNCEMENTS	NOTE 4. – RECENT ACCOUNTING PRONOUNCEMENTS In September 2015, the FASB issued ASU No. 2015-16, Business Combinations (Topic 805): Simplifying the Accounting for Measurement – Period Adjustments. This ASU simplifies the accounting for adjustments made to provisional amounts recognized in a business combination; the amendments eliminate the requirement to retrospectively account for those adjustments. This ASU will require that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. It also requires that the acquirer record, in the same period's financial statements, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed at the acquisition date. This ASU is effective for the annual and interim reporting periods beginning after December 15, 2016. We are currently evaluating whether the adoption of this new guidance will have a significant impact on our condensed consolidated financial statements and disclosures. In July 2015, the FASB issued ASU No. 2015-11, Inventory: Simplifying the Measurement of Inventory. This ASU simplifies the guidance on the subsequent measurement of inventory by requiring inventory within the scope of this update to be measured at the lower of cost or net realizable value rather than the lower of cost or market. This ASU is effective for the annual and interim reporting periods beginning after December 15, 2016. We are currently evaluating whether the adoption of this new guidance will have a significant impact on our condensed consolidated financial statements and disclosures. In April 2015, the FASB issued ASU No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs . This standard amends the existing guidance to require that debt issuance costs be presented in the balance sheet as a deduction from the carrying amount of the related debt liability instead of as a deferred charge. This ASU is effective on a retrospective basis for annual and interim reporting periods beginning after December 15, 2015, but early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company's condensed consolidated financial position and results of operations. Management continually evaluates the potential impact, if any, of all recent accounting pronouncements on our consolidated financial statements or related disclosures and, if significant, makes the appropriate disclosures required by such new accounting pronouncements.

W_R GROUP, INC.

W/R GROUP, INC.	9 Months Ended
	Sep. 30, 2015
W/R GROUP, INC. [Abstract]
W/R GROUP, INC.	NOTE 5. – W/R GROUP, INC. On August 18, 2015 and further amended on September 24, 2015, the Company entered into a definitive asset purchase agreement, dated as of August 31, 2015, with Carey Williams and Stefan Russell, the owners of all of the capital stock of W/R Group, Inc., an Arizona corporation (“WRG”). Under the terms of the asset purchase agreement, the Company and WRG Acquisition Corporation, a newly formed Arizona subsidiary of the Company (the “Buyer”) agreed to cause the Buyer to purchase 100 42.25 30.0 12.25 five 11.0 1.25 4.0 4,000,000 35

INVENTORIES

INVENTORIES	9 Months Ended
	Sep. 30, 2015
INVENTORIES [Abstract]
INVENTORIES	NOTE 6. – INVENTORIES Significant components of inventory at September 30 , 201 5 and December 31, 201 4 consist primarily of: 2015 2014 Inventory in transit $ 96,692 $ 231,623 Bulk product and raw materials 2,416,896 2,502,402 Work in process 492,049 213,832 Merchandise inventory 1,435,189 1,423,929 Less: Allowance (397,228 ) (387,258 ) $ 4,043,598 $ 3,984,528

INTANGIBLE ASSETS

INTANGIBLE ASSETS	9 Months Ended
	Sep. 30, 2015
INTANGIBLE ASSETS [Abstract]
INTANGIBLE ASSETS	NOTE 7. – INTANGIBLE ASSETS Significant components of intangible assets at September 30, 2015 and December 31, 2014 consist of: 2015 2014 Distribution rights in Brazil $ 750,000 $ 750,000 Less: Accumulated amortization (450,000 ) (393,750 ) Net distribution rights 300,000 356,250 Mexican Customer list 932,000 932,000 Less: Accumulated amortization (243,537 ) (223,162 ) Net customer list 688,463 708,838 Goodwill 36,285 36,285 $ 1,024,748 $ 1,101,373 The following table represents the amortized cost of the various assets over the remaining years; the weighted average remaining period is 5.69 Asset: 2015 2016 2017 2018 Beyond Total Brazil distribution rights $ 18,750 $ 75,000 $ 75,000 $ 75,000 $ 56,250 $ 300,000 Mexican customer list 25,875 103,500 103,500 103,500 352,088 688,463 $ 44,625 $ 178,500 $ 178,500 $ 178,500 $ 408,338 $ 988,463

ACCRUED EXPENSES

ACCRUED EXPENSES	9 Months Ended
	Sep. 30, 2015
ACCRUED EXPENSES [Abstract]
ACCRUED EXPENSES	NOTE 8. – ACCRUED EXPENSES Accrued expenses at September 30 , 201 5 and December 31, 201 4 consist of: 2015 2014 Advertising $ — $ 35,000 Commissions 422,466 367,063 Director Services 1,510 15,000 Facilities 26,862 10,300 Fees/Interest 13,967 7,000 Investor Relations 78,750 265,024 Materials 115,275 102,958 Personnel 34,780 108,819 Warehouse 28,993 55,948 $ 722,603 $ 967,112

OTHER CURRENT LIABILITIES

OTHER CURRENT LIABILITIES	9 Months Ended
	Sep. 30, 2015
OTHER CURRENT LIABILITIES [Abstract]
OTHER CURRENT LIABILITIES	NOTE 9 . – OTHER CURRENT LIABILITIES Other current liabilities at September 30, 2015 and December 31, 2014 consist of: 2015 2014 Customer deposits $ 200,070 $ 141,998 Credit cards 421,696 190,803 Marketing and promotional programs 10,438 227,681 Taxes payable - Mexico 88,929 173,567 Current portion of long term debt 11,949 11,429 Vendor Note 4,000 25,174 Advance from Officer — 26,360 Other operating liabilities 126,303 89,810 $ 863,385 $ 886,822

NOTES PAYABLE

NOTES PAYABLE	9 Months Ended
	Sep. 30, 2015
NOTES PAYABLE [Abstract]
NOTES PAYABLE	NOTE 10. – NOTES PAYABLE The Company was a party to a note payable for $ 350,000 1 191,202 350,000 37,100 The Company is party to a note payable t hat was originally issued on April 20, 2015 for $ 250,000 450,000. 1 30,000 0.85 8,000 2.50 26,049 12,440 On September 15, 2015, the warrant for 30,000 25,500

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2015
COMMITMENTS AND CONTINGENCIES [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 1 1 . – COMMITMENTS AND CONTINGENCIES During the nine months ended September 30 , 201 5 , the Company operated under several material agreements as listed below: Lease for office and production facilitie s –  The Company is party to a lease for a total of 1,875 4,725  The Company was party to a lease for 50,000 6.00 24,720 10,918 0.24 0.27 The Company's Mexican facility leases 246 1,230 20,000 1,171 The Company accounts for its facility leases using the straight-line method and incurred $ 94,895 156,393 The Company is committed to lease payments over the next five years as follows: 2015 2016 2017 2018 2019 Total Deerfield, Fl (HQ/Production) $ 109,880 $ 444,672 $ 457,238 $ 470,298 $ 278,882 $ 1,760,970 Mexico City, Mexico (Sales) 3,513 4,685 — — — 8,198 $ 113,393 $ 449,357 $ 457,238 $ 470,298 $ 278,882 $ 1,769,168 Pending and threatened litigation – On June 13, 2011, the Company filed an action in the Circuit Court of the Eleventh Judicial Circuit in and for Miami-Dade County, Florida for the rescission of an investor relations and consulting agreement entered into on or about October 15, 2010 whereby the Company paid a third party approximately $ 20,000 23,000 During 2011, the Company filed an action in the Circuit Court of the Eleventh Judicial Circuit in and for Miami-Dade County, Florida for the rescission of an agreement entered into on or about May 18, 2010 whereby the Company paid a third party approximately $ 500 20,000 10,000 10,000 60 From time to time, the Company may be involved in various claims and legal actions arising from the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company's condensed consolidated financial position or results of operations. Purchase commitments In order to secure an adequate supply of raw materials, the Company executes purchase orders to its suppliers as evidence of its intent to purchase materials. Purchase orders outstanding at September 30, 2015 totaled $ 281,741 Contract contingencies The Company's distribution agreement with Gamma Investors, a shareholder of the Company, provides that in the event the Company terminates the agreement without cause, the Company is required to repurchase all products held in Gamma's inventory and pay Gamma a fee equal to the greater of the prior 12 month product purchased by Gamma or $ 2

EQUITY

EQUITY	9 Months Ended
	Sep. 30, 2015
EQUITY [Abstract]
EQUITY	NOTE 1 2 . – EQUITY Common Stock During the first quarter of 2015, the Company issued 32,500 27,000 57,000 43,500 36,290 30,000 220,000 440,000 During the second quarter of 2015, the Company issued 15,500 28,060 412,154 380,902 5,000 8,200 440,000 2,500 6,000 200,000 328,000 218,666 During the third quarter of 2015, the Company issued 800,000 2,269,200 5 2,232,167 7,251 130,307 367,341 1.25 14,118 twelve 500,000 605,000 1,996,500 1,496,500 Effective with the appointment of each of our three non-employee directors to the Company's Board during 2015, the Company agreed to issue to each of our three non-employee directors restricted common stock that shall vest in four ( 4 25,000 67,650 Warrants During the third quarter of 2015, the Company granted warrants to one of our employees to purchase 720,000 48 15 21,614 one three two zero 2,746,200 2,643,975

SIGNIFICANT CUSTOMERS

SIGNIFICANT CUSTOMERS	9 Months Ended
	Sep. 30, 2015
SIGNIFICANT CUSTOMERS [Abstract]
SIGNIFICANT CUSTOMERS	NOTE 1 3 . – SIGNIFICANT CUSTOMERS Our product revenues represent primarily sales of Revita and Revita Cor which individually exceed 10% of total sales and collectively represent 39 7 41.0 42.7 Sales to customers individually in excess of 10% of net revenue during 2015-YTD and their accounts receivable at September 30, 2015 were: Customer Sales Amount Percent Accounts Receivable Percent C $ 1,028,010 10 $ 82,500 3 Sales to customers individually in excess of 10% of net revenue during 2014-YTD and their accounts receivable at September 30, 2014 were: Customer Sales Amount Percent Accounts Receivable Percent C $ 1,447,704 15 $ 0 0

SIGNIFICANT VENDORS

SIGNIFICANT VENDORS	9 Months Ended
	Sep. 30, 2015
SIGNIFICANT VENDORS [Abstract]
SIGNIFICANT VENDORS	NOTE 1 4 . – SIGNIFICANT VENDORS The Company purchases its raw materials from various foreign and domestic suppliers several of which represent individually in excess of 10% of total purchases. Vendor Purchase Amount Percent Accounts Payable Percent C $ 551,121 21 $ 107,646 10 D $ 377,173 15 $ 66,901 6 A $ 277,879 11 $ 26,948 3 Purchases from significant vendors during 2014-YTD and their accounts payable at September 30, 2014 were: Vendor Purchase Amount Percent Accounts Payable Percent C $ 789,233 21 $ 63,213 6

GEOGRAPHIC REVENUE REPORTING

GEOGRAPHIC REVENUE REPORTING	9 Months Ended
	Sep. 30, 2015
GEOGRAPHIC REVENUE REPORTING [Abstract]
GEOGRAPHIC REVENUE REPORTING	NOTE 1 5 . – GEOGRAPHIC REVENUE REPORTING The Company is organized based on one business segment although it does distribute its products on a world-wide basis. Several of its largest distributors are based in North America who in turn sells their products in Europe or Asia. The Company considered these customers as based in North America. Information about the Company's geographic operations for both 2015-YTD and 2014-YTD as follows: 2015 2014 Net Revenue: North America $ 4,073,951 $ 3,911,426 International 6,027,146 5,796,078 $ 10,101,097 $ 9,707,504

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2015
RELATED PARTY TRANSACTIONS [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 1 6 . – RELATED PARTY TRANSACTIONS For the nine months ended September 30 , 201 5 and 2014 , the Company was a party to the following related party transactions not disclosed elsewhere in these condensed consolidated financial statements:  the Company expensed $ 77,480 (2015) and $ 77,425 (2014) as compensation to the father of our Chairman and President for consulting on various pro jects,  the Company expensed $ 51,174 (2015) and $ 0 (2014) as compensation to the sister of our Chairman and President as a brand manager for various customers ,   the Company had receivables from a consultant, who is also a shareholder and performs various professional services, of $ 54,587 (2015) and $ 11,170 (December 31, 2014) and payable s of $ 0 (2015) and $ 11,571 (December 31, 2014). In addition, the Company had the following transact ions with the consultant: o The Company expensed $ 134,583 (2015) and $ 0 tsourced COO services. o The Company expensed $ 42,475 (2015 ) and $ 51,887 (2014) for materials needed for the assembly and manufacture of products for export, o The Company expensed $ 56,208 (2015) and $ 281,334 (2014) in ca sh and stock for IR related expenses and services. o The Company recorded sales relating to finished product of $ 69,858 (2015) and $ 9,784 (2014).

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2015
SUBSEQUENT EVENTS [Abstract]
SUBSEQUENT EVENTS	NOTE 1 7 . – SUBSEQUENT EVENTS Management has evaluated subsequent events or transactions occurring through the date the financial statements were issued. As of October 26, 2015, the Company entered into an employment agreement with Renee Barch-Niles (the “Barch-Niles Employment Agreement”) as its new Chief Executive Officer. The Barch-Niles Employment Agreement has a term beginning October 26, 2015 and ending December 31, 2019. Per the terms, Ms. Barch-Niles shall be paid an annual base salary of $ 200,000 100 3 450,000 48 9,375 15,924 1,327 2,500,000 50,000 2,500,000 50,000 3.50 100,000 one five On October 26, 2015, Mr. Daniel Khesin resigned from his position as Chief Executive Officer of the Company. Mr. Khesin will remain in his position as President and Chief Financial Officer of the Company. During the fourth quarter of 2015, the Company issued 5,930 15,000 40,000

SUMMARY OF SIGNIFICANT ACCOUN23

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2015
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Principles of Consolidation and Presentation	Principles of Consolidation and Presentation The condensed consolidated financial statements are prepared using the accrual basis of accounting where revenues and expenses are recognized in the period in which they were incurred. The basis of accounting is US GAAP. The condensed consolidated financial statements include the accounts of the Company and its operating subsidiaries DS Laboratories, Inc., Sigma Development and Holding Co., Inc., Polaris Labs, Inc., Nutra Origin, Inc. and Divine Skin Laboratories, S.A. de CV (“DS Mexico”). Also included in the condensed consolidated financial statements are the operating activities of Velocity Storage and Packaging, LLC and Wally Group, LLC , an inactive entity, which are accounted for as VIEs. All significant intercompany balances and transactions have been eliminated in consolidation.
Prior Period Reclassifications	Prior Period Reclassifications Certain prior period amounts have been reclassified for comparability with the September 3 0 , 201 5 presentation. These reclassifications had no effect on previously reported net loss.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Although these estimates are based on management's knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results. We believe our estimates and assumptions are reasonable; however, such estimates and assumptions are subject to a number of risks and uncertainties that may cause actual results to differ materially from such estimates. Significant estimates and assumptions underlying these condensed consolidated financial statements include:  Estimates of allowances for uncollectable accounts receivable,  Estimates of inventory obsolescence and overhead and labor cost allocations,  Estimates assuming future earning capacity of our intangible assets,  Estimates of value of equity transactions for services rendered,  Estimates of returned or damaged product, and  Estimates made in our deferred income tax calculations, for which there is a full valuation allowance.
Research and Development	Research and Development The Company currently maintains a functional laboratory employing a full time chemist and a lab technician that identify new technology, test product alternatives and improve existing formulations. In addition, our founder and President devotes a substantial portion of his time in identifying new technologies and formulations to develop new products and improve existing products with the newest technology available. Such activities are expensed in the year incurred. Such costs include laboratory suppli es, salaries, materials and consultant fees. These costs are classified as product development, salaries, selling, general and administrative expenses in the condensed consolidated statements of operations, and amounted to $ 108,731 and $ 209,445 for 2015 - YTD and 201 4 - YTD , respectively .
Earnings Per Share	Earnings Per Share Potentially dilutive securities are excluded from the computation of diluted net loss per share for all of the periods presented in the accompanying condensed consolidated statements of operations because the reported net loss in each of these periods results in their inclusion being anti-dilutive. Anti-dilutive securities, which consist of stock options and warrants that are not included in the diluted net loss per share calculation , consisted of an aggregate of 1,036,140 shares and 286,526 September 30 , 201 5 and 201 4, respectively .
Debt Discounts	Debt Discounts The Company records, as a discount to notes, the relative fair value of warrants issued in connection with the issuances and the intrinsic value of any conversion options based on the differences between the fair value of the underlying common stock at the commitment date of the note and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized to interest expense using the interest method over the earlier of the term of the related debt or its earliest redemption date.

INVENTORIES (Tables)

INVENTORIES (Tables)	9 Months Ended
	Sep. 30, 2015
INVENTORIES [Abstract]
Schedule of the Significant Components of Inventory	2015 2014 Inventory in transit $ 96,692 $ 231,623 Bulk product and raw materials 2,416,896 2,502,402 Work in process 492,049 213,832 Merchandise inventory 1,435,189 1,423,929 Less: Allowance (397,228 ) (387,258 ) $ 4,043,598 $ 3,984,528

INTANGIBLE ASSETS (Tables)

INTANGIBLE ASSETS (Tables)	9 Months Ended
	Sep. 30, 2015
INTANGIBLE ASSETS [Abstract]
Schedule of Intangible Assets	2015 2014 Distribution rights in Brazil $ 750,000 $ 750,000 Less: Accumulated amortization (450,000 ) (393,750 ) Net distribution rights 300,000 356,250 Mexican Customer list 932,000 932,000 Less: Accumulated amortization (243,537 ) (223,162 ) Net customer list 688,463 708,838 Goodwill 36,285 36,285 $ 1,024,748 $ 1,101,373
Schedule of Future Amortization Expense for Intangible Assets	Asset: 2015 2016 2017 2018 Beyond Total Brazil distribution rights $ 18,750 $ 75,000 $ 75,000 $ 75,000 $ 56,250 $ 300,000 Mexican customer list 25,875 103,500 103,500 103,500 352,088 688,463 $ 44,625 $ 178,500 $ 178,500 $ 178,500 $ 408,338 $ 988,463

ACCRUED EXPENSES (Tables)

ACCRUED EXPENSES (Tables)	9 Months Ended
	Sep. 30, 2015
ACCRUED EXPENSES [Abstract]
Schedule of Accrued Expenses	2015 2014 Advertising $ — $ 35,000 Commissions 422,466 367,063 Director Services 1,510 15,000 Facilities 26,862 10,300 Fees/Interest 13,967 7,000 Investor Relations 78,750 265,024 Materials 115,275 102,958 Personnel 34,780 108,819 Warehouse 28,993 55,948 $ 722,603 $ 967,112

OTHER CURRENT LIABILITIES (Tabl

OTHER CURRENT LIABILITIES (Tables)	9 Months Ended
	Sep. 30, 2015
OTHER CURRENT LIABILITIES [Abstract]
Schedule of Other Current Liabilities	2015 2014 Customer deposits $ 200,070 $ 141,998 Credit cards 421,696 190,803 Marketing and promotional programs 10,438 227,681 Taxes payable - Mexico 88,929 173,567 Current portion of long term debt 11,949 11,429 Vendor Note 4,000 25,174 Advance from Officer — 26,360 Other operating liabilities 126,303 89,810 $ 863,385 $ 886,822

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	9 Months Ended
	Sep. 30, 2015
COMMITMENTS AND CONTINGENCIES [Abstract]
Schedule of Future Minimum Operating Lease Payments	2015 2016 2017 2018 2019 Total Deerfield, Fl (HQ/Production) $ 109,880 $ 444,672 $ 457,238 $ 470,298 $ 278,882 $ 1,760,970 Mexico City, Mexico (Sales) 3,513 4,685 — — — 8,198 $ 113,393 $ 449,357 $ 457,238 $ 470,298 $ 278,882 $ 1,769,168

SIGNIFICANT CUSTOMERS (Tables)

SIGNIFICANT CUSTOMERS (Tables)	9 Months Ended
	Sep. 30, 2015
SIGNIFICANT CUSTOMERS [Abstract]
Schedule of Sales to Significant Customers	Sales to customers individually in excess of 10% of net revenue during 2015-YTD and their accounts receivable at September 30, 2015 were: Customer Sales Amount Percent Accounts Receivable Percent C $ 1,028,010 10 $ 82,500 3 Sales to customers individually in excess of 10% of net revenue during 2014-YTD and their accounts receivable at September 30, 2014 were: Customer Sales Amount Percent Accounts Receivable Percent C $ 1,447,704 15 $ 0 0

SIGNIFICANT VENDORS (Tables)

SIGNIFICANT VENDORS (Tables)	9 Months Ended
	Sep. 30, 2015
SIGNIFICANT VENDORS [Abstract]
Schedule of Significant Purchases from Vendors	Vendor Purchase Amount Percent Accounts Payable Percent C $ 551,121 21 $ 107,646 10 D $ 377,173 15 $ 66,901 6 A $ 277,879 11 $ 26,948 3 Vendor Purchase Amount Percent Accounts Payable Percent C $ 789,233 21 $ 63,213 6

GEOGRAPHIC REVENUE REPORTING (T

GEOGRAPHIC REVENUE REPORTING (Tables)	9 Months Ended
	Sep. 30, 2015
GEOGRAPHIC REVENUE REPORTING [Abstract]
Schedule of Revenues by Geographic Area	2015 2014 Net Revenue: North America $ 4,073,951 $ 3,911,426 International 6,027,146 5,796,078 $ 10,101,097 $ 9,707,504

SUMMARY OF SIGNIFICANT ACCOUN32

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Summary Of Significant Accounting Policies [Line Items]
Contracted research and development expense	$ 108,731	$ 209,445
Antidilutive stock options and warrants	1,036,140	286,526

LIQUIDITY and GOING CONCERN (De

LIQUIDITY and GOING CONCERN (Details) - USD ($)	9 Months Ended
	Sep. 30, 2015	Dec. 31, 2014	Sep. 30, 2014	Dec. 31, 2013
LIQUIDITY and GOING CONCERN [Abstract]
Cash	$ 1,375,290	$ 1,128,556	$ 493,947	$ 2,872,946
Accumulated deficit	10,279,667	$ 9,613,375
Online sale revenue	$ 415,078

W_R GROUP, INC. (Details)

W/R GROUP, INC. (Details) - WRG [Member] - USD ($)	Aug. 31, 2015	Oct. 26, 2015
W/R GROUP, INC. [Line Items]
Voting interest acquired (as a percent)	100.00%
Cash consideration to stockholders	$ 30,000,000
Earn-out amount paid in cash	11,000,000
Value of shares paid in earn-out provision	1,250,000
Addition cash consideration to stockholders	4,000,000
Outstanding accrued principal and interest payable under secured promissory note assumed	4,000,000
Non-convertible senior debt [Member]
W/R GROUP, INC. [Line Items]
Principle amount		$ 35,000,000
Maximum [Member]
W/R GROUP, INC. [Line Items]
Total consideration	42,250,000
Earn-out payment	$ 12,250,000
Earn-out payment term	5 years

INVENTORIES (Details)

INVENTORIES (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
INVENTORIES [Abstract]
Inventory in transit	$ 96,692	$ 231,623
Bulk product and raw materials	2,416,896	2,502,402
Work in process	492,049	213,832
Merchandise inventory	1,435,189	1,423,929
Less: Allowance	(397,228)	(387,258)
Inventory, net, total	$ 4,043,598	$ 3,984,528

INTANGIBLE ASSETS (Schedule of

INTANGIBLE ASSETS (Schedule of Intangible Assets) (Details) - USD ($)	9 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Goodwill	$ 36,285	$ 36,285
Total intangible assets	$ 1,024,748	1,101,373
Weighted average remaining amortization period	5 years 8 months 8 days
Distribution rights in Brazil [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, gross	$ 750,000	750,000
Finite-lived intangible asset, accumulated amortization	(450,000)	(393,750)
Finite-lived intangible assets, net, total	300,000	356,250
Mexican Customer list [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, gross	932,000	932,000
Finite-lived intangible asset, accumulated amortization	(243,537)	(223,162)
Finite-lived intangible assets, net, total	$ 688,463	$ 708,838

INTANGIBLE ASSETS (Schedule o37

INTANGIBLE ASSETS (Schedule of Future Amortization Expense for Intangible Assets) (Details)	Sep. 30, 2015USD ($)
Finite-Lived Intangible Assets [Line Items]
2,015	$ 44,625
2,016	178,500
2,017	178,500
2,018	178,500
Beyond	408,338
Amortized cost of assets	988,463
Brazil distribution rights [Member]
Finite-Lived Intangible Assets [Line Items]
2,015	18,750
2,016	75,000
2,017	75,000
2,018	75,000
Beyond	56,250
Amortized cost of assets	300,000
Mexican Customer list [Member]
Finite-Lived Intangible Assets [Line Items]
2,015	25,875
2,016	103,500
2,017	103,500
2,018	103,500
Beyond	352,088
Amortized cost of assets	$ 688,463

ACCRUED EXPENSES (Details)

ACCRUED EXPENSES (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Accrued expenses:
Advertising		$ 35,000
Commissions	$ 422,466	367,063
Director Services	1,510	15,000
Facilities	26,862	10,300
Fees/Interest	13,967	7,000
Investor Relations	78,750	265,024
Materials	115,275	102,958
Personnel	34,780	108,819
Warehouse	28,993	55,948
Total Accrued expenses	$ 722,603	$ 967,112

OTHER CURRENT LIABILITIES (Deta

OTHER CURRENT LIABILITIES (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
OTHER CURRENT LIABILITIES [Abstract]
Customer deposits	$ 200,070	$ 141,998
Credit cards	421,696	190,803
Marketing and promotional programs	10,438	227,681
Taxes payable - Mexico	88,929	173,567
Current portion of long term debt	11,949	11,429
Vendor Note	$ 4,000	25,174
Advance from Officer		26,360
Other operating liabilities	$ 126,303	89,810
Other current liabilities	$ 863,385	$ 886,822

NOTES PAYABLE (Details)

NOTES PAYABLE (Details) - USD ($)	Sep. 15, 2015	Apr. 20, 2015	Dec. 31, 2014	Sep. 30, 2015
Notes payable [Line Items]
Note payable			$ 350,000	$ 437,560
Warrants [Member]
Notes payable [Line Items]
Aggregate fair value of warrants				26,049
Unamortized discount amount				$ 12,440
Warrants issued	30,000
Value of warrants issued	$ 25,500
Warrants [Member] | April 20, 2017 [Member]
Notes payable [Line Items]
Warrants available to purchase, shares				30,000
Exercise price of warrants (in dollars per share)				$ 0.85
Expiration date of warrants				Apr. 20, 2017
Warrants [Member] | September 1, 2017 [Member]
Notes payable [Line Items]
Warrants available to purchase, shares				8,000
Exercise price of warrants (in dollars per share)				$ 2.50
Expiration date of warrants				Sep. 1, 2017
Notes payable [Member]
Notes payable [Line Items]
Note payable		$ 250,000	$ 350,000	$ 450,000
Maturity date		Dec. 31, 2015	May 28, 2015
Monthly interest rate (as a percent)		1.00%	1.00%
Shares issued upon conversion of debt	191,202
Converted instrument principle amount	$ 350,000
Converted instrument accrued interest amount	$ 37,100

COMMITMENTS AND CONTINGENCIES41

COMMITMENTS AND CONTINGENCIES (Leases for Office and Production Facilities) (Details)	9 Months Ended			12 Months Ended
	Sep. 30, 2015USD ($)ft²	Sep. 30, 2015MXN	Sep. 30, 2014USD ($)	Dec. 31, 2014
Operating Leased Assets [Line Items]
Rent expenses	$ 94,895		$ 156,393
2,015	113,393
2,016	449,357
2,017	457,238
2,018	470,298
2,019	278,882
Total	1,769,168
Deerfield, Fl (HQ/Production) [Member]
Operating Leased Assets [Line Items]
Monthly rent payment	24,720
Operating leases, rent expense, annually, net	10,918
Per square foot price of lease	6
Minimum annual increase in monthly rent per square foot.	0.24
Maximum annual increase in monthly rent per square foot	$ 0.27
Lease expiration period	Jul. 31, 2019	Jul. 31, 2019		Jul. 31, 2014
Area of real estate space | ft²	50,000
2,015	$ 109,880
2,016	444,672
2,017	457,238
2,018	470,298
2,019	278,882
Total	1,760,970
Ashville, North Carolina (Sales) [Member]
Operating Leased Assets [Line Items]
Monthly rent payment	$ 4,725
Lease expiration period	Dec. 31, 2015	Dec. 31, 2015
Area of real estate space | ft²	1,875
Mexico City, Mexico (Sales) [Member]
Operating Leased Assets [Line Items]
Monthly rent payment	$ 1,171	MXN 20,000
Lease expiration period	Apr. 30, 2016	Apr. 30, 2016
2,015	$ 3,513
2,016	$ 4,685
2,017
2,018
2,019
Total	$ 8,198
Mexico City, Mexico (Sales) [Member] | Office Building [Member]
Operating Leased Assets [Line Items]
Area of real estate space | ft²	246
Mexico City, Mexico (Sales) [Member] | Warehouse [Member]
Operating Leased Assets [Line Items]
Area of real estate space | ft²	1,230

COMMITMENTS AND CONTINGENCIES42

COMMITMENTS AND CONTINGENCIES (Pending and Threatened Litigation and Purchase Commitments) (Details) - USD ($)	1 Months Ended		9 Months Ended	12 Months Ended
	Mar. 31, 2014	Jun. 30, 2011	Sep. 30, 2015	Dec. 31, 2011
Loss Contingencies [Line Items]
Amount paid for prior services		$ 20,000		$ 500
Litigation for recission, number of shares		23,000		20,000
Number of common shares the defendant agreed to return to Company	10,000
Number of common shares remaining, 60% subject to a one year lock up agreement	10,000
Percentage of common shares subject to a one year lock up agreement	60.00%
Long-term Purchase Commitment [Line Items]
Purchase orders outstanding			$ 281,741
Fees required to pay by company if contract terminated			$ 2,000,000

EQUITY (Common Stock) (Details)

EQUITY (Common Stock) (Details)	3 Months Ended			9 Months Ended
	Sep. 30, 2015USD ($)shares	Jun. 30, 2015USD ($)shares	Mar. 31, 2015USD ($)shares	Sep. 30, 2015USD ($)itemshares
Stockholders Equity Note [Line Items]
Subscriptions sold, shares not issued			$ 220,000
Subscriptions sold, shares not issued, shares | shares			440,000
IR Firm [Member]
Stockholders Equity Note [Line Items]
Stock issued as compensation for service | shares	7,251	15,500	57,000
Issuance of common stock for services		$ 28,060	$ 43,500
Directors [Member]
Stockholders Equity Note [Line Items]
Stock issued as compensation for service | shares		5,000
Issuance of common stock for services		$ 8,200
Consultant [Member]
Stockholders Equity Note [Line Items]
Stock subscription	$ 218,666			$ 218,666
Stock issued as compensation for service | shares		200,000
Issuance of common stock for services deliverable ratably over the upcoming year		$ 328,000
Investors [Member]
Stockholders Equity Note [Line Items]
Stock subscription	$ 1,496,500			1,496,500
Stock issued as compensation for service | shares	605,000	440,000
Issuance of common stock for services	$ 1,996,500
Proceeds from sale of stock subscription	500,000
Subscriptions sold, shares not issued		$ 2,500
Shares retured to treasury | shares		6,000
Distributors [Member]
Stockholders Equity Note [Line Items]
Stock subscription	$ 2,232,167			2,232,167
Stock issued as compensation for service | shares	800,000		32,500
Issuance of common stock for services	$ 2,269,200		$ 27,000
Service term	5 years
Three Employees [Member]
Stockholders Equity Note [Line Items]
Stock issued as compensation for service | shares			36,290
Issuance of common stock for services			$ 30,000
Five Employees [Member]
Stockholders Equity Note [Line Items]
Stock issued as compensation for service | shares		412,154
Issuance of common stock for services		$ 380,902
Eight employees [Member]
Stockholders Equity Note [Line Items]
Stock issued as compensation for service | shares	130,307
Vesting period	1 year 3 months
Unearned compensation cost	$ 14,118			$ 14,118
Recognized period of unearned compensation cost	12 months
Investor relations firm and eight employee [Member]
Stockholders Equity Note [Line Items]
Issuance of common stock for services	$ 367,341
Three non-employee directors [Member]
Stockholders Equity Note [Line Items]
Number of equal tranches | item				4
Restricted shares issued | shares				25,000
Value of restricted shares issued				$ 67,650

EQUITY (Warrants) (Details)

EQUITY (Warrants) (Details) - Warrants [Member]	9 Months Ended
	Sep. 30, 2015USD ($)item$ / sharesshares
Warrants [Line Items]
Aggregate fair value of warrants	$ 26,049
Employees [Member]
Warrants [Line Items]
Number of employees | item	2
Exercise price of warrants (in dollars per share) | $ / shares	$ 0
Aggregate fair value of warrants	$ 2,746,200
Unamortized unrecognized compensation cost	$ 2,643,975
Employee, one [Member]
Warrants [Line Items]
Warrants available to purchase, shares | shares	720,000
Vesting period	48 months
Expiration period	15 years
Employee, two [Member]
Warrants [Line Items]
Warrants available to purchase, shares | shares	21,614
Vesting period	1 year
Expiration period	3 years

SIGNIFICANT CUSTOMERS (Details)

SIGNIFICANT CUSTOMERS (Details) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Concentration Risk [Line Items]
Accounts Receivable	$ 3,173,576		$ 1,809,178
Customer C [Member] | Accounts Receivable [Member]
Concentration Risk [Line Items]
Concentration risk percentage	3.00%	0.00%
Accounts Receivable	$ 82,500	$ 0
Customer C [Member] | Sales Amount [Member]
Concentration Risk [Line Items]
Sales Amount	$ 1,028,010	$ 1,447,704
Concentration risk percentage	10.00%	15.00%
Spectral DNC-N [Member] | Net Revenue [Member]
Concentration Risk [Line Items]
Concentration risk percentage	7.00%
Top Ten Customers [Member] | Net Revenue [Member]
Concentration Risk [Line Items]
Concentration risk percentage	41.00%	42.70%
Revita and Revita Cor [Member] | Net Revenue [Member]
Concentration Risk [Line Items]
Concentration risk percentage	39.00%

SIGNIFICANT VENDORS (Details)

SIGNIFICANT VENDORS (Details) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Concentration Risk [Line Items]
Accounts payable	$ 1,171,798		$ 1,229,863
Vendor A [Member] | Purchase Amount [Member]
Concentration Risk [Line Items]
Purchase Amount	$ 277,879
Concentration risk percentage	11.00%
Vendor A [Member] | Accounts Payable [Member]
Concentration Risk [Line Items]
Accounts payable	$ 26,948
Concentration risk percentage	3.00%
Vendor C [Member] | Purchase Amount [Member]
Concentration Risk [Line Items]
Purchase Amount	$ 551,121	$ 789,233
Concentration risk percentage	21.00%	21.00%
Vendor C [Member] | Accounts Payable [Member]
Concentration Risk [Line Items]
Accounts payable	$ 107,646	$ 63,213
Concentration risk percentage	10.00%	6.00%
Vendor D [Member] | Purchase Amount [Member]
Concentration Risk [Line Items]
Purchase Amount	$ 377,173
Concentration risk percentage	15.00%
Vendor D [Member] | Accounts Payable [Member]
Concentration Risk [Line Items]
Accounts payable	$ 66,901
Concentration risk percentage	6.00%

GEOGRAPHIC REVENUE REPORTING (D

GEOGRAPHIC REVENUE REPORTING (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Segment Reporting Information [Line Items]
Net revenue	$ 3,637,629	$ 3,278,117	$ 10,101,097	$ 9,707,504
North America [Member]
Segment Reporting Information [Line Items]
Net revenue			4,073,951	3,911,426
International [Member]
Segment Reporting Information [Line Items]
Net revenue			$ 6,027,146	$ 5,796,078

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Father of Chairman and President [Member]
Related Party Transaction [Line Items]
Expense incurred with related party	$ 77,480	$ 77,425
Sister of Chairman and President [Member]
Related Party Transaction [Line Items]
Expense incurred with related party	51,174	0
Consultant [Member]
Related Party Transaction [Line Items]
Related party receivables	54,587		$ 11,170
Related party payables	0		$ 11,571
Consultant [Member] | Outsourced COO services [Member]
Related Party Transaction [Line Items]
Expense incurred with related party	134,583	0
Consultant [Member] | Purchase of Materials Needed for Assembly and Manufacture of Products for Export [Member]
Related Party Transaction [Line Items]
Expense incurred with related party	42,475	51,887
Consultant [Member] | IR related expenses and services [Member]
Related Party Transaction [Line Items]
Expense incurred with related party	56,208	281,334
Consultant [Member] | Finished product purchased and resold [Member]
Related Party Transaction [Line Items]
Amount received	$ 69,858	$ 9,784

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - USD ($)	Oct. 26, 2015	Dec. 31, 2015	Jun. 30, 2015
Consultant [Member]
SUBSEQUENT EVENTS [Line Items]
Issuance of common stock for services, shares			200,000
SUBSEQUENT EVENTS [Member] | Renee Barch Niles [Member]
SUBSEQUENT EVENTS [Line Items]
Base annual salary	$ 200,000
Percentage of maximum cash bonus paid on base salary	100.00%
Percentage of commission receive on gross sales amount for new account or client acquisition	3.00%
Number of bonus shares granted	15,924
Number of shares vesting per month for 12 consecutive months	1,327
SUBSEQUENT EVENTS [Member] | Renee Barch Niles [Member] | Warrant [Member]
SUBSEQUENT EVENTS [Line Items]
Warrants receivable	$ 100,000
Expiration period	1 year
Number of trading days for calculation of average price	5 days
SUBSEQUENT EVENTS [Member] | Renee Barch Niles [Member] | Maximum [Member]
SUBSEQUENT EVENTS [Line Items]
Value of shares granted	$ 2,500,000
Additional shares issued	2,500,000
SUBSEQUENT EVENTS [Member] | Renee Barch Niles [Member] | Minimum [Member]
SUBSEQUENT EVENTS [Line Items]
Value of shares granted	50,000
Additional shares issued	$ 50,000
Share price (in dollars per share)	$ 3.50
SUBSEQUENT EVENTS [Member] | Renee Barch Niles [Member] | Restricted Stock [Member]
SUBSEQUENT EVENTS [Line Items]
Grants (in shares)	450,000
Vesting period	48 months
Number of shares vesting per month	9,375
SUBSEQUENT EVENTS [Member] | Consultant [Member]
SUBSEQUENT EVENTS [Line Items]
Issuance of common stock for services, shares		5,930
Issuance of common stock for services		$ 15,000
SUBSEQUENT EVENTS [Member] | Employee [Member]
SUBSEQUENT EVENTS [Line Items]
Issuance of common stock for services, shares		40,000